News

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
If you're one of the millions of Americans who have used or thought about using GLP-1 weight-loss drugs, it’s important to ...
New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...
Xavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...
Explore more
Learn about SYNT-101, the emerging treatment for obesity that combines the best of two proven methods.
The companies are allegedly selling "research grade" GLP-1 weight loss drugs that are not FDA-approved, and are selling the products without a pharmacy license.
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...
Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at ...
The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...
Former FDA Commissioner Dr. David Kessler has just released an important new book on diet and wieght loss. He spoke to Forbes ...